Real-life Study of the Characteristics of Patients Treated With Ilaris® (Canakinumab) for Gouty Arthritis in France
Clinical trial NCT05964946 · COMPLETED
Trial details
- NCT number
- NCT05964946
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-06-24
- Primary completion
- 2022-07-29
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.